CRISPR Therapeutics AG (CRSP)
54.12
+2.65
(+5.15%)
USD |
NASDAQ |
Oct 28, 16:00
53.70
-0.42
(-0.78%)
After-Hours: 20:00
CRISPR Therapeutics Market Cap : 5.231B for Oct. 28, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 27, 2026 | 4.975B |
| October 26, 2026 | 4.737B |
| October 23, 2026 | 4.774B |
| October 22, 2026 | 4.832B |
| October 21, 2026 | 4.881B |
| October 20, 2026 | 4.821B |
| October 19, 2026 | 4.837B |
| October 16, 2026 | 4.761B |
| October 15, 2026 | 4.980B |
| October 14, 2026 | 4.854B |
| October 13, 2026 | 4.843B |
| October 12, 2026 | 4.983B |
| October 09, 2026 | 5.161B |
| October 08, 2026 | 4.876B |
| October 07, 2026 | 5.060B |
| October 06, 2026 | 5.220B |
| October 05, 2026 | 5.543B |
| October 02, 2026 | 5.358B |
| October 01, 2026 | 5.359B |
| September 30, 2026 | 5.347B |
| September 29, 2026 | 5.413B |
| September 28, 2026 | 5.228B |
| September 25, 2026 | 5.242B |
| September 24, 2026 | 5.384B |
| September 23, 2026 | 5.390B |
| Date | Value |
|---|---|
| September 22, 2026 | 5.706B |
| September 21, 2026 | 5.638B |
| September 18, 2026 | 5.467B |
| September 17, 2026 | 5.541B |
| September 16, 2026 | 5.047B |
| September 15, 2026 | 5.010B |
| September 14, 2026 | 5.119B |
| September 11, 2026 | 4.999B |
| September 10, 2026 | 5.052B |
| September 09, 2026 | 5.167B |
| September 08, 2026 | 5.295B |
| September 04, 2026 | 5.393B |
| September 03, 2026 | 5.460B |
| September 02, 2026 | 5.502B |
| September 01, 2026 | 5.492B |
| August 31, 2026 | 5.508B |
| August 28, 2026 | 5.579B |
| August 27, 2026 | 5.739B |
| August 26, 2026 | 5.725B |
| August 25, 2026 | 5.887B |
| August 24, 2026 | 5.517B |
| August 21, 2026 | 5.751B |
| August 20, 2026 | 5.618B |
| August 19, 2026 | 5.781B |
| August 18, 2026 | 5.120B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vertex Pharmaceuticals, Inc. | 134.24B |
| Basilea Pharmaceutica AG | 945.73M |
| Santhera Pharmaceuticals Holding AG | 274.57M |
| BeOne Medicines Ltd. | 38.90B |
| Intellia Therapeutics, Inc. | 1.864B |
Market Cap Related Metrics
| PS Ratio | 383.05 |
| Price to Book Value | 2.995 |
| Price | 54.12 |
| Earnings Yield | -8.80% |